tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OVID Stock Latest News

Ovid Therapeutics expands scientific advisory board
The FlyOvid Therapeutics expands scientific advisory board
4d ago
OVID
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
PremiumPress Releases
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
4d ago
OVID
Ovid Therapeutics announces eNeuro published studies on OV329 mechanism
PremiumThe Fly
Ovid Therapeutics announces eNeuro published studies on OV329 mechanism
17d ago
OVID
eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
PremiumPress Releases
eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
17d ago
OVID
Ovid Therapeutics, Graviton announce data from trial of OV888/GV101 capsule
PremiumThe Fly
Ovid Therapeutics, Graviton announce data from trial of OV888/GV101 capsule
26d ago
OVID
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
PremiumPress ReleasesOvid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
26d ago
OVID
Ovid Therapeutics Announces Workforce Reduction to Extend Runway
PremiumCompany Announcements
Ovid Therapeutics Announces Workforce Reduction to Extend Runway
28d ago
8K
OVID
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
TAK
ARDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
TAK
AVTE
Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls
1M ago
KR
GSK
Ovid Therapeutics price target lowered to $3 from $9 at B. Riley
PremiumThe Fly
Ovid Therapeutics price target lowered to $3 from $9 at B. Riley
1M ago
TAK
OVID
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
PremiumThe Fly
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
1M ago
TAK
OVID
Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg
PremiumThe FlyOvid Therapeutics price target lowered to $2 from $7 at Ladenburg
1M ago
TAK
OVID
Ovid Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Ovid Therapeutics downgraded to Perform from Outperform at Oppenheimer
1M ago
OVID
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
1M ago
TAK
OVID
Ovid Therapeutics price target lowered to $1.20 from $3.50 at Citi
PremiumThe Fly
Ovid Therapeutics price target lowered to $1.20 from $3.50 at Citi
1M ago
OVID
Ovid Therapeutics Announces Phase 3 Results with Takeda
PremiumCompany Announcements
Ovid Therapeutics Announces Phase 3 Results with Takeda
1M ago
8K
OVID
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
PremiumPress Releases
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
1M ago
OVID
Ovid Therapeutics sees cash runway into 1H26
PremiumThe Fly
Ovid Therapeutics sees cash runway into 1H26
1M ago
OVID
Ovid Therapeutics notes Takeda’s announcement on Phase 3 results of soticlestat
PremiumThe FlyOvid Therapeutics notes Takeda’s announcement on Phase 3 results of soticlestat
1M ago
TAK
OVID
Ovid Therapeutics participates in a conference call with Truist
PremiumThe Fly
Ovid Therapeutics participates in a conference call with Truist
2M ago
OVID
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
PremiumPress Releases
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
2M ago
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >